Floatz logo

Panobinostat

Metastatic Pancreatic Carcinoma

H. Lee Moffitt Cancer Center and Research InstituteSmall moleculePhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Metastatic Pancreatic Carcinoma cohort.

Asset / SponsorPhaseRating
Capecitabine
Zhejiang University
Phase 2BB
Docetaxel
Eli Lilly and Company
Phase 2B
Hydroxychloroquine
Northwestern University
Phase 2B
Gefetinib
Dana-Farber Cancer Institute
Phase 2B
Rivoceranib
Zhejiang University
Phase 2CCC

View all 14 →

Same molecule, other indications

Panobinostat is also rated in:

Hodgkins lymphomaDormant
BB
Indicative ·
68 / 100
View asset →
Non-Small Cell Lung CancerDormant
BB
Indicative ·
66 / 100
View asset →
chronic lymphocytic leukemia/small lymphocytic lymphomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →